Inactive Instrument
Innate Immunotherapeutics Ltd Stock Australian S.E.
Stocks
AU000000IIL6
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 56.46M 39.35M 35.1M 32.71M 29.76M 56.05M 3.79B 395M 154M 1.93B 148M 145M 6.22B | P/E 2027 * |
-4.78x | P/E 2028 * | -15.7x |
|---|---|---|---|---|---|
| Enterprise Value | 38.56M 26.88M 23.98M 22.34M 20.33M 38.28M 2.59B 270M 105M 1.32B 101M 98.72M 4.25B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 3.48x |
| Free-Float |
90.48% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 day | -2.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 05/12/2022 | |
Hamish George
DFI | Director of Finance/CFO | - | 01/10/2021 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 02/09/2015 |
Warwick Tong
CHM | Chairman | - | 25/05/2018 |
Jane Bell
CHM | Chairman | - | 30/06/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.33% | -10.64% | - | - | 39.24M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -0.37% | -3.81% | +19.51% | +78.12% | 57.39B | |
| +1.63% | -1.61% | +3.16% | +36.89% | 47.64B | |
| +1.31% | +3.24% | +347.16% | +724.56% | 44.29B | |
| +2.05% | -2.90% | +28.34% | +33.01% | 42.5B | |
| +0.78% | -1.74% | +4.66% | +111.28% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +54.06% | 30.97B | |
| +1.56% | +4.53% | +31.34% | +26.92% | 28.53B | |
| +0.44% | -0.76% | -6.49% | -10.49% | 24.34B | |
| Average | +0.85% | -0.59% | +54.04% | +127.61% | 43.39B | |
| Weighted average by Cap. | +1.46% | -0.84% | +58.19% | +136.83% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 9.5M 6.62M 5.91M 5.5M 5.01M 9.43M 638M 66.49M 25.87M 325M 24.85M 24.32M 1.05B |
| Net income | -11.6M -8.08M -7.21M -6.72M -6.11M -11.51M -779M -81.19M -31.59M -397M -30.35M -29.69M -1.28B | -4.1M -2.86M -2.55M -2.37M -2.16M -4.07M -275M -28.7M -11.16M -140M -10.73M -10.5M -451M |
| Net Debt | -17.9M -12.47M -11.13M -10.37M -9.44M -17.77M -1.2B -125M -48.74M -613M -46.83M -45.82M -1.97B | -23.4M -16.31M -14.55M -13.55M -12.33M -23.23M -1.57B -164M -63.72M -802M -61.22M -59.9M -2.58B |
Employees
-
